Clinical trial · Observational

Involved Nodal Irradiation vs Involved Field Irradiation After Cth in Ttt of Early Stages HDs

NCT05284396CI-TRIAL-00057181unknownClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

determine the early toxicity and loco-regional control comparing outcome of radiothrapy rither by using INRT or IFRT in treatment of early stage hodgkin lymphoma determine progression-free survival and late toxisty

Conditions

Conditions (1)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Hodgkin Lymphoma	Hodgkin Lymphoma	ONTOLOGY_EXACT	0.90

Interventions

Interventions (1)

Intervention	Type	Mapped drug	Match
IFRT vs NFRT	Radiation	—	UNRESOLVED

Design

Arms and outcomes

Arms (0)

[]

Primary outcomes (1)

measure
Comparison between different irradiation modalities in tretment of early stage hodgkin lymphoma
timeFrame
baseline
description
involved nodal Irradiation versus Involved field Irradiation after Chemotherapy in treatment of Early stage Hodgkin's lymphoma

Eligibility

Eligibility (as posted)

Sex: All
Minimum age: 18 Years
Maximum age: 75 Years

Show eligibility criteria text

Inclusion Criteria:

* Histologically proven Hodgkin's Lymphoma, with exclusion of the nodular lymphocyte predominant subtybe
* Clinical stage I or II, only supra-diaphragmatic nodes, both favorable and unfavorable prognostic subsets
* Previously untreated.
* Age: between 18 and 75 years.
* Good general condition(WHO performance status 0-2).
* Free of concurrent disease.

Exclusion Criteria:

* Patients with impaired heart, lung, liver, or kidney function.
* Previous malignant diseases or HIV-positive status
* Patient with advanced or infra-diaghragmatic Hodgkin's disease
* Pregnant or lactating women
* Patient with prior irradiation to the neck and thorathic region

References

Publications (0)

Data not yet available

No reference posted for this study.